Show results for
Refine by
Cancer Patient Equipment Supplied In Europe
66 equipment items found
Manufactured by:Abologix based inGeneva, SWITZERLAND
Junction Adhesion Molecule C (JAM-C) has been studied at the laboratories of Prof. Beat Imhof and Prof. Thomas Matthes at the Université de Genève for over 10+ years (36 peer reviewed publications). There is in addition 60+ publications from other laboratories. JAM-C is expressed by certain lymphocytes and prominently localises to tight junctions of endotelial cells. In many ...
Manufactured by:Abologix based inGeneva, SWITZERLAND
Olfactomedin-like protein 3 (Olfml3) creates an angiogenic environment in tumours and is associated with vascular growth factors BMP-4 and PDGF. Olfml3 is overexpressed in some cancers. Blocking Olfml3 with highly specific monoclonal antibodies is therefore a logical scientific approach in order to develop new generation inhibitors of angiogenesis. Abologix has produced several recombinant ...
Manufactured by:Caelus Health based inAmsterdam, NETHERLANDS
CH-0701: the fourth drug intervention is based on FMT in Cancer cachexia; the primary objective is to extend the application of FMT to late and earlier stage cancer ...
Manufactured by:Emosis Diagnostics SAS based inIllkirch-Graffenstaden, FRANCE
Primary aim is in assessing procoagulant states associated with cancer and cancer therapies, to inform physician’s decision making on initiating, pursuing or stopping anticoagulant prophylaxis in cancer patient. ...
Manufactured by:MV BioTherapeutics SA based inBellinzona, SWITZERLAND
The ApyraMed technology exploits a recombinant live biotherapeutic that promotes adaptive intestinal homeostasis. In cancer patients, it enhances immune system competence, whereas in dysbiosis safeguards the intestinal ...
Manufactured by:Sequana Medical NV based inSint-Denijs Westrem, BELGIUM
Ascites is also a common complication of certain late-stage cancers due to fluid build-up in the peritoneal cavity from a number of causes including draining of the lymph system. While life expectancy for many cancer patients with malignant ascites is short (less than 3 months), ovarian and breast cancer patients ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
Manufactured by:2A Pharma ApS based inAalborg Øst, DENMARK
Head and neck cancers represent the sixth most common cancer worldwide, resulting in more than 350,000 deaths/year. Our AAVLP-HNC vaccine uses our mimotope selection technology and has the potential to minimize side effects, improve efficacy, and markedly reduce treatment costs. This will address an unmet medical need and benefit cancer ...
Manufactured by:3B Pharmaceuticals GmbH based inBerlin, GERMANY
Targeted radiopharmaceuticals bind to specific structures such as proteins or cells within the body and thus accumulate in particular places, such as e.g. tumor lesions in a cancer ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
A reliable tool to personalize therapy of lung cancer patients with acquired TKI-resistance mutation T790M in the EGFR ...
Manufactured by:VUP Medical, a.s. based inBrno, CZECH REPUBLIC
ARAVEL medical underwear is designed for cancer patients after radiotherapy who suffer from a consultative skin reaction, either in the form of erythema or consultative dermatitis. It is made of polypropylene fibers, which give it lightness and breathability. The use of this product can help in the management of deliberative changes and contribute to an improved ...
Manufactured by:BioVariance GmbH based inKonnersreuther Str. 6g, GERMANY
Using genetics to identify the best possible medication for your individual patient! OncoVariant supports physicians in interpreting the genetic alterations of their cancer patients. BioVariance has developed a web-based platform to identify the most suitable medication based on the patient’s own genetic variants. Any ...
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify therapeutic options for cancer patients not able to have their tumor biopsied or whose biopsy is too old. It can be used ...
Manufactured by:2A Pharma ApS based inAalborg Øst, DENMARK
2A Pharma’s AAVLP-HER2/Neu peptide vaccine candidate has in laboratory tests been shown to induce antibodies specific to human HER2. In mouse models, regression of breast cancer tumors was observed after vaccination. In a proof-of-principle study carried out at the Medical University of Vienna, Austria, supported by Medigene AG, it was concluded that this vaccine strategy ...
by:NEC OncoImmunity AS based inOslo, NORWAY
Recent advances in the field of immuno-oncology have established that mutated antigens (neoantigens), are viable targets of the immune system, potentially specific to each individual cancer patient. This plus many other breakthroughs in immuno-oncology and the rapid advances in next generation sequencing (NGS), opens up exciting new opportunities to harness ...
Manufactured by:ICU Medical, Inc. based inSan Clemente, CALIFORNIA (USA)
With the ChemoLock needlefree CSTD, it has never been easier to keep yourself safe from exposure to hazardous drugs. Treating cancer patients takes compassion—it shouldn’t take a toll on your health. But the fact is, while chemotherapy is the backbone of medical oncology, these powerful medications—along with many others—are extremely ...
by:RaySearch Laboratories based inStockholm, SWEDEN
Save time and reduce the risk of error by automating treatment planning. Advanced plan-generating protocols, scripting, automated breast planning, fallback planning, machine learning and plan explorer are some of the tools available in RayStation — the first treatment planning system to incorporate machine learning applications. ...
by:IBA based inLouvain-La-Neuve, BELGIUM
Proteus® has been inspired by everyday clinical practice. Through day-to-day interactions with the community, IBA is perfectly positioned to understand, and invest in, the user’s needs. These investments are directly translated into benefits for the patients. The Proteus® design enhances the patient experience by fostering a soothing environment while making the medical ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
NSCLC comprises approximately 85% of all lung cancers. Tumor specimens from patients should be tested for the presence of EGFR mutations prior to TKI treatment. The EGFR XL StripAssay® and EGFR T790M RealFast™ Assay are designed to assist clinicians in the stratification of patients considered for TKI ...